Midas Letter

Subversive Capital’s philosophy is aligned with Midas Letters core thesis: The company is dedicated to investing in radical companies whose core missions subvert the status quo. Where Midas Letter speaks directly to companies and CEO’s within emerging markets, Subversive Capital invests in […]

BioMind Labs Inc (NEO:BMND, OTCMKTS:CRSWF) has a long history of working with psychedelic compounds. Its scientific research date all the way back to 2006 in Brazil. Its initial workings were to understand the impact of Ayahuasca on the brain. Through these studies, […]

Australis Capital Inc (OTCMKTS:AUSAF, CNSX:AUSA) is now operating as AUDACIOUS Brands. Audacious stands for doing things differently and breaking with tradition. AUDACIOUS is breaking away from becoming a fintech company, as it was before Terry Booth was appointed CEO. Instead, Terry Booth […]

Get ready to be blown away with the magnitudes of guests we have on this week’s show! A 90-minute special that will fill your Friday and weekend with mind-altering perspectives on all your favourite stock market trends. Commodities, psychedelics, weed stocks, and […]

Did you know 53% of the world is not connected to the internet? That is a big problem that needs a robust solution. Luckily, NuRAN Wireless Inc (CNSX:NUR, OTCMKTS:NRRWF) offers the world’s most affordable, lowest power consumption and easiest to deploy wireless solutions. NuRAN builds […]

For our weed stocks audience, you may compare COMPASS Pathways PLC (NASDAQ:CMPS) to the Canopy Growth Corp (NASDAQ:CGC, TSE:WEED) of the first cannabis bull run. The bellwether of their industry. COMPASS Pathways has developed a proprietary formulation of Psilocybin (the hallucinogenic magic mushroom) and […]

Planet 13 Holdings Inc (OTCMKTS:PLNHF, CNSX:PLTH) has dominated the Nevada market with its marijuana tourism destination SuperStore. The world’s largest dispensary dominates cannabis sales on the Las Vegas Strip. Planet 13 took its first step in becoming a multi-state operator (MSO), opening […]

Since we last spoke with Mind Medicine (MindMed) Inc (NASDAQ:MNMD, NEO:MMED), the company has completed a transition of its Chief Executive Officer. The new CEO’s main mission for shareholders is simple: to build the best drug pipeline in psychedelics. Robert Barrow has previously […]

Do you trust mainstream financial journalism? Or do you sometimes read between the lines and see ulterior motives? Why did so many cannabis stocks rise so high only to disappear? What did Chairman Gary Gensler reveal about the SEC’s future of crypto […]

Have you ever wished you could invest in an early-stage psychedelic company before it went public? What about gaining exposure to a diverse portfolio of many private shroom boom companies? Early-stage investing has risks, but the rewards can be life-changing. Well, an […]